Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Hypertension. 2015 Nov 9;67(1):63–69. doi: 10.1161/HYPERTENSIONAHA.115.06480

TABLE 2.

Association of Achieved SBP and Outcomes

SBP < 124 mmHg
(N=747)
SBP ≥124 mmHg
(N=2000)
Model HR per SD* Higher SBP
(95% CI)
p-value for
interaction
All Stroke
# of events 45 130
Model 1 0.44 (0.21, 0.93) 1.3 (1.1, 1.7) 0.005
Model 2 0.40 (0.19, 0.84) 1.3 (0.97, 1.7) 0.005
Model 3 0.43 (0.17, 1.1) 1.1 (0.76, 1.6) 0.02
Ischemic Stroke
# of events 38 110
Model 1 0.43 (0.19, 0.99) 1.4 (1.1, 1.7) 0.01
Model 2 0.38 (0.17, 0.87) 1.3 (0.92, 1.7) 0.01
Model 3 0.41 (0.15, 1.1) 1.0 (0.70, 1.6) 0.03
Major Vascular Events
# of events 53 178
Model 1 0.45 (0.22, 0.90) 1.4 (1.2, 1.7) 0.001
Model 2 0.41 (0.20, 0.84) 1.4 (1.1, 1.8) 0.0008
Model 3 0.53 (0.22, 1.3) 1.1 (0.84, 1.5) 0.005
Death
# of events 38 119
Model 1 0.45 (0.20, 1.0) 1.5 (1.2, 1.8) 0.001
Model 2 0.40 (0.17, 0.93) 1.9 (1.5, 2.4) <0.001
Model 3 0.29 (0.10, 0.79) 1.9 (1.4, 2.7) <0.001
*

11.1 mmHg

Model 1 includes age, sex, ethnicity, region, smoking, alcohol use, BMI, baseline SBP, baseline DBP, history of hypertension, diabetes, heart disease, or prior stroke/TIA; Model 2 adds number of medications at baseline and number of medications at 1 year follow-up, and randomization group, Model 3 adds achieved DBP (linear and quadratic term)